Editorial: Malignant hypertension.
D001794:Blood Pressure; D002302:Cardiac Output; D003981:Diazoxide / Q000627:therapeutic use; D005292:Ferricyanides / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000188:drug therapy*; D009569:Nitric Oxide / Q000627:therapeutic use; D012964:Sodium / Q000652:urine; D014665:Vasodilator Agents / Q000627:therapeutic use
D005292:Ferricyanides; D014665:Vasodilator Agents; D006830:Hydralazine; D009569:Nitric Oxide; D005665:Furosemide; D012964:Sodium; D003981:Diazoxide